siRNA-targeted inhibition of growth hormone receptor in human colon cancer SW480 cells.

about

Growth hormone is permissive for neoplastic colon growth.Obesity, diabetes and cancer: insight into the relationship from a cohort with growth hormone receptor deficiency.

P2860

Q37183586-BA82F805-0AE8-47C9-8FB4-2E9B25D95B67 Q38260335-12D1E552-4DBA-4374-B82F-A950E5E6787B

P2860

siRNA-targeted inhibition of growth hormone receptor in human colon cancer SW480 cells.

Item

http://www.wikidata.org/entity/Q37358681

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

siRNA-targeted inhibition of growth hormone receptor in human colon cancer SW480 cells.

@en

siRNA-targeted inhibition of growth hormone receptor in human colon cancer SW480 cells.

@nl

type

Item

label

siRNA-targeted inhibition of growth hormone receptor in human colon cancer SW480 cells.

@en

siRNA-targeted inhibition of growth hormone receptor in human colon cancer SW480 cells.

@nl

prefLabel

siRNA-targeted inhibition of growth hormone receptor in human colon cancer SW480 cells.

@en

siRNA-targeted inhibition of growth hormone receptor in human colon cancer SW480 cells.

@nl

P1476

siRNA-targeted inhibition of growth hormone receptor in human colon cancer SW480 cells.

@en

P2093

Dong Zhou

http://www.w3.org/2001/XMLSchema#string

Jie Yang

http://www.w3.org/2001/XMLSchema#string

Jun Wang

http://www.w3.org/2001/XMLSchema#string

Qiang Zhang

http://www.w3.org/2001/XMLSchema#string

Wei-Dong Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

Does growth hormone cause cancer?

Cancer statistics, 2009

The role of STAT proteins in growth hormone signaling.

Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study.

The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth.

Growth hormone can act as a cytokine controlling survival and proliferation of immune cells: new insights into signaling pathways.

Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer.

Blocking oncogenes in malignant cells by RNA interference--new hope for a highly specific cancer treatment?

Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis.

P304

8108-8113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V19.I44.8108

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24307807

http://www.w3.org/2001/XMLSchema#string

P932

3848161

http://www.w3.org/2001/XMLSchema#string

siRNA-targeted inhibition of growth hormone receptor in human colon cancer SW480 cells.

about

P2860

P2860

siRNA-targeted inhibition of growth hormone receptor in human colon cancer SW480 cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932